Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1989 1
1990 1
1991 3
1992 2
1993 5
1994 5
1995 6
1996 2
1997 5
1998 5
1999 7
2000 21
2001 16
2002 12
2003 22
2004 15
2005 14
2006 20
2007 16
2008 13
2009 8
2010 12
2011 19
2012 17
2013 11
2014 13
2015 18
2016 10
2017 12
2018 6
2019 5
2020 16
2021 15
2022 13
2023 16
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

359 results

Results by year

Filters applied: . Clear all
Page 1
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial.
Rummel MJ, Niederle N, Maschmeyer G, Banat GA, von Grünhagen U, Losem C, Kofahl-Krause D, Heil G, Welslau M, Balser C, Kaiser U, Weidmann E, Dürk H, Ballo H, Stauch M, Roller F, Barth J, Hoelzer D, Hinke A, Brugger W; Study group indolent Lymphomas (StiL). Rummel MJ, et al. Lancet. 2013 Apr 6;381(9873):1203-10. doi: 10.1016/S0140-6736(12)61763-2. Epub 2013 Feb 20. Lancet. 2013. PMID: 23433739 Clinical Trial.
Bortezomib induction and maintenance treatment in patients with newly diagnosed multiple myeloma: results of the randomized phase III HOVON-65/ GMMG-HD4 trial.
Sonneveld P, Schmidt-Wolf IG, van der Holt B, El Jarari L, Bertsch U, Salwender H, Zweegman S, Vellenga E, Broyl A, Blau IW, Weisel KC, Wittebol S, Bos GM, Stevens-Kroef M, Scheid C, Pfreundschuh M, Hose D, Jauch A, van der Velde H, Raymakers R, Schaafsma MR, Kersten MJ, van Marwijk-Kooy M, Duehrsen U, Lindemann W, Wijermans PW, Lokhorst HM, Goldschmidt HM. Sonneveld P, et al. Among authors: schmidt wolf ig. J Clin Oncol. 2012 Aug 20;30(24):2946-55. doi: 10.1200/JCO.2011.39.6820. Epub 2012 Jul 16. J Clin Oncol. 2012. PMID: 22802322 Free article. Clinical Trial.
Lenalidomide in multiple myeloma.
Kim Y, Schmidt-Wolf IG. Kim Y, et al. Among authors: schmidt wolf ig. Expert Rev Anticancer Ther. 2015 May;15(5):491-7. doi: 10.1586/14737140.2015.1033407. Epub 2015 Apr 5. Expert Rev Anticancer Ther. 2015. PMID: 25843431 Review.
Fluorescent Probes for Ecto-5'-nucleotidase (CD73).
Schmies CC, Rolshoven G, Idris RM, Losenkova K, Renn C, Schäkel L, Al-Hroub H, Wang Y, Garofano F, Schmidt-Wolf IGH, Zimmermann H, Yegutkin GG, Müller CE. Schmies CC, et al. Among authors: schmidt wolf igh. ACS Med Chem Lett. 2020 Sep 3;11(11):2253-2260. doi: 10.1021/acsmedchemlett.0c00391. eCollection 2020 Nov 12. ACS Med Chem Lett. 2020. PMID: 33214837 Free PMC article.
Gene therapy of lymphoma.
Buttgereit P, Schmidt-Wolf IG. Buttgereit P, et al. Among authors: schmidt wolf ig. J Hematother Stem Cell Res. 2002 Jun;11(3):457-67. doi: 10.1089/15258160260090924. J Hematother Stem Cell Res. 2002. PMID: 12183831 Review.
Improvements in Flow Cytometry-Based Cytotoxicity Assay.
Wu X, Zhang Y, Li Y, Schmidt-Wolf IGH. Wu X, et al. Among authors: schmidt wolf igh. Cytometry A. 2021 Jul;99(7):680-688. doi: 10.1002/cyto.a.24242. Epub 2020 Oct 31. Cytometry A. 2021. PMID: 33068327 Free article.
359 results